// App-Quantinova.ai

1515 : Infections in Patients with Active Radiographic Axial Spondyloarthritis Treated with Ixekizumab in 2 Phase 3 Clinical Trials

Researchers

Presenter

  • Victoria Navarro-Compan

Principal Investigators

  • Sandra Garces

  • Xenofon Baraliakos

  • David Sandoval

  • Jeffrey Lisse

  • Silvia Santisteban

  • David Adams

  • Fangyi Zhao

  • Robert Inman

Medical Centers

  • Division of Rheumatology, The MetroHealth System and School of Medicine, Case Western Reserve University, Cleveland, OH

  • University Hospital La Paz, Madrid, Spain

  • Eli Lilly and Company, Indianapolis, IN

  • Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Herne, Germany

  • University of Toronto, University Health Network, Toronto, Ontario, Canada

Locations

  • United States

  • Spain

  • Germany

  • Canada

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Sacroiliitis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • LY2439821

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • NCT02696785

  • NCT02696798

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved